A Multicenter, Open-label, Single-arm, Non-inferiority Study to Assess the Safety and Efficacy of a Tacrolimus Modified Release, ADVAGRAF in Stable Kidney Transplant Patients Converted From a PROGRAF Based Immunosuppressive Regimen

Trial Profile

A Multicenter, Open-label, Single-arm, Non-inferiority Study to Assess the Safety and Efficacy of a Tacrolimus Modified Release, ADVAGRAF in Stable Kidney Transplant Patients Converted From a PROGRAF Based Immunosuppressive Regimen

Completed
Phase of Trial: Phase IV

Latest Information Update: 05 May 2013

At a glance

  • Drugs Tacrolimus (Primary)
  • Indications Renal transplant rejection
  • Focus Therapeutic Use
  • Acronyms PeACE
  • Most Recent Events

    • 07 Jun 2017 Biomarkers information updated
    • 05 May 2013 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top